Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.02.25.707643

VECTR-Clasp: An open machine-learning and vector-based framework for objective quantification of motor dysfunction during hind-limb clasping in Cdkl5-deficient mice

Abstract

Quantitative assessment of motor behaviour in rodents is central to the study of neurological disease, yet it remains constrained by manual categorical scoring systems that limit sensitivity, reproducibility, and the ability to detect subtle phenotypes. The hind-limb clasping assay, a standard test of motor dysfunction across many mouse models, is typically scored on an observer-defined categorical scale that may overlook meaningful movement features. We developed VECTR-Clasp, an open vector-based geometric framework that transforms standard pose-estimation output into continuous, body-relative kinematic measures. Combining DeepLabCut for markerless pose estimation with SimBA for automated clasping classification, our pipeline first reproduces conventional clasping detection at a level of agreement approaching that between trained human raters, and then extracts continuous geometric descriptors, including head directionality, total distance travelled, and swing count, that are inaccessible to categorical scoring. Applied to a mouse model of CDKL5 deficiency disorder, a rare neurodevelopmental condition in which motor impairment is a core clinical feature, this approach revealed previously uncharacterised motor microphenotypes: affected animals showed more constrained head direction, reduced overall movement, and fewer swings than wildtype controls. Critically, these differences were also present in affected animals that displayed no overt clasping. Together, these findings demonstrate that continuous geometric analysis of pose-estimation data uncovers motor phenotypes beyond the resolution of categorical scales, providing a more sensitive and reproducible framework for quantifying motor dysfunction. As it operates on standard pose-estimation output, the approach extends readily to other behavioural assays, disease models, and the evaluation of therapeutic interventions. Author SummaryMany neurological disorders impair movement, and researchers frequently study these deficits in mouse models. A widely used test lifts a mouse by the tail and records whether it retracts its hind limbs towards its body, a reflex associated with motor dysfunction. Traditionally, an observer watches the animal and assigns a categorical score. This approach depends on human judgement, varies between raters, and can miss subtle movement differences. We developed VECTR-Clasp, an open-source pipeline that validates machine-learning pose tracking to automate traditional clasping assessment and extends current methods using vector-based geometry. This quantifies the direction and extent of head and body movements, providing additional motor readouts. In a mouse model of CDKL5 deficiency disorder, a rare paediatric neurological disorder, VECTR-Clasp matched human scoring while revealing kinematic differences missed by standard assessment, including in animals appearing unaffected. This objective, sensitive framework could detect subtle motor changes and treatment responses across neurological diseases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Higgins, J., Egan, S., Harrison, K., El-Mansoury, B., Henshall, D. C., Mamad, O.. 2026-02-26. VECTR-Clasp: An open machine-learning and vector-based framework for objective quantification of motor dysfunction during hind-limb clasping in Cdkl5-deficient mice. https://doi.org/10.64898/2026.02.25.707643

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗